FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980087859> ?p ?o ?g. }

• W1980087859 endingPage "206" @default.
• W1980087859 startingPage "199" @default.
• W1980087859 abstract "Background Highly pathogenic avian influenza A H5N1 viruses are widespread in different parts of the world and have evolved into clade 1 and 2 lineages. Their continuing circulation represents serious pandemic threat, spurring human vaccine development efforts. Initial clinical trials tested vaccines prepared from clade 1 strains circulating in 2004. Methods Post‐vaccination sera from a phase I trial of an inactivated split‐virion vaccine based on A/Vietnam/1194/2004/NIBRG14 (H5N1) were analysed in vitro for cross‐reactivity against highly pathogenic, wild‐type clade 2 H5N1 strains isolated from human cases, and their corresponding reverse genetics derived vaccine candidate strains. Results Neutralisation of clade 1 and 2 wild‐type and reverse‐genetics viruses was seen, with highest titres observed for viruses most closely related to the vaccine strain. There was no consistent relationship between vaccine dose given, or presence of aluminium adjuvant and cross‐neutralising antibody titre, possibly because of small sample size. Use of wild‐type highly pathogenic strains compared with antigenically equivalent reverse‐genetics viruses suggests presence of a higher level of cross‐neutralising antibody. Conclusion Vaccination with a clade 1 H5N1 virus elicited antibodies capable of neutralising diverse clade 2 H5N1 strains. This data underlines that while a close match between vaccine virus and circulating virus is important to achieve maximum protection, population priming with a ‘pre‐pandemic’ vaccine may be beneficial for the protection of a naïve population. The data suggests that use of reverse‐genetic viruses in neutralisation assays may underestimate the extent of cross‐protective antibody present following H5N1 vaccination." @default.
• W1980087859 created "2016-06-24" @default.
• W1980087859 creator A5013386229 @default.
• W1980087859 creator A5024597692 @default.
• W1980087859 creator A5048822204 @default.
• W1980087859 creator A5049136341 @default.
• W1980087859 creator A5055194670 @default.
• W1980087859 creator A5072485453 @default.
• W1980087859 creator A5080592111 @default.
• W1980087859 date "2007-09-01" @default.
• W1980087859 modified "2023-10-17" @default.
• W1980087859 title "Cross‐neutralisation of antibodies elicited by an inactivated split‐virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains" @default.
• W1980087859 cites W1808739935 @default.
• W1980087859 cites W1964398303 @default.
• W1980087859 cites W1976670588 @default.
• W1980087859 cites W1980284814 @default.
• W1980087859 cites W1987016144 @default.
• W1980087859 cites W1987669718 @default.
• W1980087859 cites W2005047889 @default.
• W1980087859 cites W2019759746 @default.
• W1980087859 cites W2039776316 @default.
• W1980087859 cites W2040635697 @default.
• W1980087859 cites W2059293792 @default.
• W1980087859 cites W2065069831 @default.
• W1980087859 cites W2075649492 @default.
• W1980087859 cites W2077332396 @default.
• W1980087859 cites W2082232086 @default.
• W1980087859 cites W2106767752 @default.
• W1980087859 cites W2108601768 @default.
• W1980087859 cites W2114555019 @default.
• W1980087859 cites W2129860791 @default.
• W1980087859 cites W2129922773 @default.
• W1980087859 cites W2131123265 @default.
• W1980087859 cites W2131155472 @default.
• W1980087859 cites W2131170401 @default.
• W1980087859 cites W2144894027 @default.
• W1980087859 cites W2274519842 @default.
• W1980087859 cites W3104828118 @default.
• W1980087859 doi "https://doi.org/10.1111/j.1750-2659.2007.00033.x" @default.
• W1980087859 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4941882" @default.
• W1980087859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19453427" @default.
• W1980087859 hasPublicationYear "2007" @default.
• W1980087859 type Work @default.
• W1980087859 sameAs 1980087859 @default.
• W1980087859 citedByCount "13" @default.
• W1980087859 countsByYear W19800878592012 @default.
• W1980087859 countsByYear W19800878592013 @default.
• W1980087859 countsByYear W19800878592015 @default.
• W1980087859 countsByYear W19800878592020 @default.
• W1980087859 crossrefType "journal-article" @default.
• W1980087859 hasAuthorship W1980087859A5013386229 @default.
• W1980087859 hasAuthorship W1980087859A5024597692 @default.
• W1980087859 hasAuthorship W1980087859A5048822204 @default.
• W1980087859 hasAuthorship W1980087859A5049136341 @default.
• W1980087859 hasAuthorship W1980087859A5055194670 @default.
• W1980087859 hasAuthorship W1980087859A5072485453 @default.
• W1980087859 hasAuthorship W1980087859A5080592111 @default.
• W1980087859 hasBestOaLocation W19800878591 @default.
• W1980087859 hasConcept C104317684 @default.
• W1980087859 hasConcept C14086860 @default.
• W1980087859 hasConcept C141231307 @default.
• W1980087859 hasConcept C142724271 @default.
• W1980087859 hasConcept C159047783 @default.
• W1980087859 hasConcept C159654299 @default.
• W1980087859 hasConcept C22070199 @default.
• W1980087859 hasConcept C2522874641 @default.
• W1980087859 hasConcept C25365240 @default.
• W1980087859 hasConcept C2776872762 @default.
• W1980087859 hasConcept C2777546802 @default.
• W1980087859 hasConcept C2779134260 @default.
• W1980087859 hasConcept C2780689484 @default.
• W1980087859 hasConcept C2908647359 @default.
• W1980087859 hasConcept C3008058167 @default.
• W1980087859 hasConcept C44465124 @default.
• W1980087859 hasConcept C519248777 @default.
• W1980087859 hasConcept C524204448 @default.
• W1980087859 hasConcept C54355233 @default.
• W1980087859 hasConcept C71924100 @default.
• W1980087859 hasConcept C7842527 @default.
• W1980087859 hasConcept C82988372 @default.
• W1980087859 hasConcept C86803240 @default.
• W1980087859 hasConcept C89423630 @default.
• W1980087859 hasConcept C89623803 @default.
• W1980087859 hasConcept C90132467 @default.
• W1980087859 hasConcept C99454951 @default.
• W1980087859 hasConceptScore W1980087859C104317684 @default.
• W1980087859 hasConceptScore W1980087859C14086860 @default.
• W1980087859 hasConceptScore W1980087859C141231307 @default.
• W1980087859 hasConceptScore W1980087859C142724271 @default.
• W1980087859 hasConceptScore W1980087859C159047783 @default.
• W1980087859 hasConceptScore W1980087859C159654299 @default.
• W1980087859 hasConceptScore W1980087859C22070199 @default.
• W1980087859 hasConceptScore W1980087859C2522874641 @default.
• W1980087859 hasConceptScore W1980087859C25365240 @default.
• W1980087859 hasConceptScore W1980087859C2776872762 @default.
• W1980087859 hasConceptScore W1980087859C2777546802 @default.
• W1980087859 hasConceptScore W1980087859C2779134260 @default.
• W1980087859 hasConceptScore W1980087859C2780689484 @default.

• next